Brad H. Rovin

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

Brad H. Rovin, Sharon G. Adler, Jonathan Barratt et al. · Kidney International · 2021 · 2.2K citations · Full text

Glomerular Disease, Glomerulonephritis, Hemodialysis +14

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations

The Influence of <i>CCL3L1</i> Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

Enrique A. González, Hemant Kulkarni, Héctor Bolívar et al. · Science · 2005 · 1.1K citations

Genetics, Immunology, Molecular Genetics +16

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 903 citations · Full text

Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

Brad H. Rovin, Sharon G. Adler, Jonathan Barratt et al. · Kidney International · 2021 · 726 citations · Full text